Safi R. Bahcall
2010
In 2010, Safi R. Bahcall earned a total compensation of $1.2M as President and Chief Executive Officer at Synta Pharmaceuticals, a 41% increase compared to previous year.
Compensation breakdown
| Bonus | $162,000 |
|---|---|
| Option Awards | $524,800 |
| Salary | $401,666 |
| Stock Awards | $55,633 |
| Other | $82,312 |
| Total | $1,226,411 |
Bahcall received $524.8K in option awards, accounting for 43% of the total pay in 2010.
Bahcall also received $162K in bonus, $401.7K in salary, $55.6K in stock awards and $82.3K in other compensation.
Rankings
In 2010, Safi R. Bahcall's compensation ranked 4,590th out of 10,439 executives tracked by ExecPay. In other words, Bahcall earned more than 56.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,590 out of 10,439 | 56th |
Division Manufacturing | 1,642 out of 3,838 | 57th |
Major group Chemicals And Allied Products | 334 out of 921 | 64th |
Industry group Drugs | 186 out of 680 | 73rd |
Industry Pharmaceutical Preparations | 144 out of 481 | 70th |
Source: SEC filing on April 29, 2013.
Bahcall's colleagues
We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2010.